Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation

BACKGROUND: In 2010 a new diagnostic test for tuberculosis, Xpert MTB/RIF, received a conditional programmatic recommendation from WHO. Several model-based economic evaluations predicted that Xpert would be cost-effective across sub-Saharan Africa. We investigated the cost-effectiveness of Xpert in...

Descripción completa

Detalles Bibliográficos
Autores principales: Vassall, Anna, Siapka, Mariana, Foster, Nicola, Cunnama, Lucy, Ramma, Lebogang, Fielding, Katherine, McCarthy, Kerrigan, Churchyard, Gavin, Grant, Alison, Sinanovic, Edina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471605/
https://www.ncbi.nlm.nih.gov/pubmed/28619229
http://dx.doi.org/10.1016/S2214-109X(17)30205-X

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5471605/
https://www.ncbi.nlm.nih.gov/pubmed/28619229
http://dx.doi.org/10.1016/S2214-109X(17)30205-X

Ejemplares similares